Chris Dockendorff

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Escherichia Coli

Biofilm Formation

Molecular Docking

Top Venues

The Journal of organic chemistry

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Barry W Festoff, Chris Dockendorff
The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies. Biomolecules 11 (11) (2021)
Saravanan Subramaniam, Yamini Ogoti, Irene Hernandez, Mark Zogg, Fady Botros, Robert Burns, Jacob T DeRousse, Chris Dockendorff, Nigel Mackman, Silvio Antoniak, Craig Fletcher, Hartmut Weiler
A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C). Blood advances 5 (13) (2021)
Mark W Majewski, Disha M Gandhi, Trudy Holyst, Zhengli Wang, Irene Hernandez, Ricardo Rosas, Jieqing Zhu, Hartmut Weiler, Chris Dockendorff
Synthesis and initial pharmacology of dual-targeting ligands for putative complexes of integrin αVβ3 and PAR2. RSC medicinal chemistry 11 (8) (2020)
Yibiao Wu, Chris Dockendorff
Synthesis of Simplified Azasordarin Analogs as Potential Antifungal Agents. The Journal of organic chemistry 84 (9) (2019)
Chris Dockendorff, Disha M Gandhi, Ian H Kimball, Kenneth S Eum, Radda Rusinova, Helgi I Ingólfsson, Ruchi Kapoor, Thasin Peyear, Matthew W Dodge, Stephen F Martin, Richard W Aldrich, Olaf S Andersen, Jon T Sack
Synthetic Analogues of the Snail Toxin 6-Bromo-2-mercaptotryptamine Dimer (BrMT) Reveal That Lipid Bilayer Perturbation Does Not Underlie Its Modulation of Voltage-Gated Potassium Channels. Biochemistry 57 (18) (2018)